Skip to content
Home/Companies/Biotech/TRIMTECH Therapeutics
TRIMTECH Therapeutics

TRIMTECH Therapeutics

Biotech·UK·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns TRIMTECH Therapeutics?

TRIMTECH Therapeutics is currently owned by Cambridge Innovation Capital through CIC Fund II (2022 vintage), since 2025. Across its history, TRIMTECH Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-05-29

Cambridge Innovation Capital
Most recent investor
Cambridge Innovation Capital
CIC Fund II · 2022 · VC
2 ownership periods · full history below

Key facts

HQUK
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-invest · 2 holders · 2023 · present
SV Health Managers
2023 · present(3yr) · Dementia Discovery Fund · 2015 · Impact
Cambridge Innovation Capital
2025 · present(1yr) · CIC Fund II · 2022 · VC
Track TRIMTECH Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on TRIMTECH Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue